Funding in, findings out

For any dataset: the NCI award that paid to create it, and the awards that got a published finding out of it afterwards.

Pick a dataset

332 of 602 datasets have at least one award resolved. 31 have awards on both sides.

Datasets with awards on both sides - awards that paid to create it awards that funded work using it

TCGA-THYM 17 → 22 ORGANOID-PANCREATIC 13 → 49 CPTAC-3 10 → 36 WCDT-MCRPC 9 → 43 TCGA-STAD 18 → 10 BEATAML1.0-COHORT 7 → 33

CTSP-DLBCL1

CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303

10 awards paid to create it · 13 awards funded work that used it

Awards that paid to create this data (6 of 10)

Credited on the dataset's own marker paper

The dataset

Articles that used it (6)

The accession appears in their methods section

Awards those articles were funded by (6 of 13)

NCI money spent on data it did not pay to generate

The best connected are shown.

CTSP-DLBCL1CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303GDC

The best connected are shown.

Direct evidence: the award is on the paper, or the accession is in the articleWeaker: infrastructure support, or use declared but not shownHover any card to follow its chain

Awards that paid to create this data

Credited on the dataset's own marker paper.

Award	Project	Evidence
P30CA006927 P30FY2019–2026$29.7M	Biostatistics and Bioinformatics Facility Eric Andrew Ross, Margaret von Mehren · RESEARCH INST OF FOX CHASE CAN CTR	API
P30CA008748 P30FY1985–2026$718.6M	Antitumor Assessment Elisa de Stanchina, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	API2
U10CA049957 U10FY1989–2013$7.4M	Eastern Cooperative Oncology Group JORDAN D BERLIN, DAVID H JOHNSON · VANDERBILT UNIVERSITY	API
U10CA180799 U10FY2014–2018$2.8M	National Clinical Trials Network Research at the University of Wisconsin Bethany M Anderson, DAVID M KUSHNER · UNIVERSITY OF WISCONSIN-MADISON	API
U10CA180820 U10FY2014–2026$256.4M	ECOG-ACRIN Network Group Operations Center Peter J ODwyer, MITCHELL D. SCHNALL · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION	API
U10CA180821 U10FY2014–2026$276.2M	Alliance for Clinical Trials in Oncology Member Site Core Evanthia Galanis, Olwen Hahn · ALLIANCE NCTN FOUNDATION	API
U10CA180833 U10FY2014–2018$7.6M	Washington University/ Siteman Cancer Center Lead Academic Site NANCY L BARTLETT, Benjamin D Kozower · WASHINGTON UNIVERSITY	API
U10CA180847 U10FY2014–2018$2.6M	Vanderbilt Network Lead Academic Participating Site for the NCTN JORDAN D BERLIN · VANDERBILT UNIVERSITY MEDICAL CENTER	API
U10CA180882 U10FY2014–2026$172.9M	Data Management Core Sumithra Jay Mandrekar, DANIEL J. SARGENT · MAYO CLINIC ROCHESTER	API
U10CA180888 U10FY2014–2026$231.9M	SWOG Network Group Operations Center of the NCTN DAWN HERSHMAN, PRIMO N. LARA · UNIVERSITY OF CALIFORNIA AT DAVIS	API

Awards that funded work using this data

6 of 10 traced articles report an NCI award. 1 of these awards also paid to create the data - the same team publishing again on its own cohort, not a duplicated row.

Award	Project	Articles it is credited on	Evidence
U01CA157581 U01FY2011–2015$3.1M	Molecular Diagnosis and Prognosis in Aggressive Lymphoma Lisa Rimsza · MAYO CLINIC ARIZONA	A multiprotein supercomplex controlling oncogenic signalling in lymphoma. 2018 Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic… 2024	API
P01CA229100 P01FY2018–2022$20.5M	Preclinical Models and Therapeutics Core Giorgio Inghirami, David William Scott · MAYO CLINIC ARIZONA	Compromised counterselection by FAS creates an aggressive subtype of germinal center lymp… 2021	API
P30CA023108 P30FY1985–2026$196.5M	Signaling, Genomes, and Networks Arminja Nadine Kettenbach, KEITH D. PAULSEN · DARTMOUTH COLLEGE	Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic… 2024	API
P30CA008748 P30FY1985–2026$718.6M	Antitumor Assessment Elisa de Stanchina, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadrup… 2020	API2
T32CA009149 T32FY1985–2022$6.1M	Immunology Research Training Alexander Y Rudensky, JAMES P ALLISON · SLOAN-KETTERING INST CAN RESEARCH	A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadrup… 2020	API
U54CA132378 U54FY2008–2025$52.1M	Planning and Evaluation Core (PEC) ADRIANA ESPINOSA, Sanna M Goyert · CITY COLLEGE OF NEW YORK	A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadrup… 2020	API
U54CA137788 U54FY2008–2026$52.4M	Outreach Core (PCORE) Jennifer CF Leng, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadrup… 2020	API
K08CA237856 K08FY2020–2024$976k	Mechanisms of non-genetic variation in melanoma Salil Garg · YALE UNIVERSITY	Developmental Deconvolution for Classification of Cancer Origin. 2022	API
P30CA014051 P30FY1985–2026$195.2M	Leadership, Planning and Evaluation MATTHEW G. VANDER HEIDEN, Omer Yilmaz · MASSACHUSETTS INSTITUTE OF TECHNOLOGY	Developmental Deconvolution for Classification of Cancer Origin. 2022	API
R37CA225655 R37FY2018–2024$3.0M	Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications Kamila Naxerova · HARVARD MEDICAL SCHOOL	Developmental Deconvolution for Classification of Cancer Origin. 2022	API
P30CA016058 P30FY1985–2026$258.1M	Shared Resource 10: Pharmacoanalytical Shared Resource (PhASR) Mitch A Phelps, David M Gosky · OHIO STATE UNIVERSITY	Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo. 2021	API
P30CA033572 P30FY1985–2026$174.5M	Clinical Protocol and Data Management Alex F. Herrera, JOHN D. CARPTEN · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE	Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo. 2021	API
R01CA194742 R01FY2016–2021$2.7M	Reolysin-based combination therapy in relapsed multiple myeloma Craig C. Hofmeister, Flavia Pichiorri · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE	Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo. 2021	API

Awards that maintain or redistribute this data

Resource and center grants credited on articles that used the data. Kept out of the flow above because they pay for the pipes, not for a cohort or a finding.

Award	Project	Evidence
P01CA229100 P01FY2018–2022$20.5M	Preclinical Models and Therapeutics Core Giorgio Inghirami, David William Scott · MAYO CLINIC ARIZONA	API
P30CA014051 P30FY1985–2026$195.2M	Leadership, Planning and Evaluation MATTHEW G. VANDER HEIDEN, Omer Yilmaz · MASSACHUSETTS INSTITUTE OF TECHNOLOGY	API
P30CA016058 P30FY1985–2026$258.1M	Shared Resource 10: Pharmacoanalytical Shared Resource (PhASR) Mitch A Phelps, David M Gosky · OHIO STATE UNIVERSITY	API
P30CA023108 P30FY1985–2026$196.5M	Signaling, Genomes, and Networks Arminja Nadine Kettenbach, KEITH D. PAULSEN · DARTMOUTH COLLEGE	API
P30CA033572 P30FY1985–2026$174.5M	Clinical Protocol and Data Management Alex F. Herrera, JOHN D. CARPTEN · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE	API
U01CA157581 U01FY2011–2015$3.1M	Molecular Diagnosis and Prognosis in Aggressive Lymphoma Lisa Rimsza · MAYO CLINIC ARIZONA	API
U54CA132378 U54FY2008–2025$52.1M	Planning and Evaluation Core (PEC) ADRIANA ESPINOSA, Sanna M Goyert · CITY COLLEGE OF NEW YORK	API
U54CA137788 U54FY2008–2026$52.4M	Outreach Core (PCORE) Jennifer CF Leng, FRANCESCA M GANY · SLOAN-KETTERING INST CAN RESEARCH	API

Where the links come from

NIH RePORTER maps a PMID to the awards that reported it. On a dataset’s marker paper that gives the awards which created it; on an article that used the data, the awards which funded that use.

The two sides are not measured alike. Generation is complete: a dataset has one marker paper and every award on it is resolved. Reuse is a sample - the articles using a dataset can number in the thousands, and only the few dozen strongest are retrieved and looked up. Every award shown here funded reuse; there are more that are not shown.

How far it reaches

283 datasets have an award credited with creating them, 80 with using them, and 31 both.

What is missing

No citable accession means no traceable articles; no authoritative marker paper means no attributable generation award. Absence is a gap in the record. Methods.

Start from an award instead, and see every dataset it touches.